Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Olga Mulas

Showing results (11-20 of 57) with videos related to

Pageof 6
Sort By:
Acta Haematologica|September 6, 2020
Rituximab Monotherapy or in Combination with Bendamustine Is Not Inferior to Rituximab-CHOP Regimen in the Treatment of Patients with Splenic Marginal Zone Lymphoma in the Real LifeOlga Mulas, Giovanni Caocci, Daniela Dessì, et al.
Journal of Clinical Medicine|April 13, 2023
Long-Term Health-Related Quality of Life and Clinical Outcomes in Patients with β-Thalassemia after SplenectomyGiovanni Caocci, Olga Mulas, Susanna Barella, et al.
Diagnostics (Basel, Switzerland)|August 26, 2022
Pathogenic and Prognostic Roles of Paraneoplastic Leukocytosis in Cervical Cancer: Can Genomic-Based Targeted Therapies Have a Role? A Literature Review and an Emblematic Case ReportClelia Madeddu, Elisabetta Sanna, Sonia Nemolato, et al.
Clinical Practice and Epidemiology in Mental Health : CP & EMH|April 21, 2022
Health-Related Quality of Life Assessment in Patients with Myelodysplastic Syndromes: Evidence from Randomized Clinical TrialsJohannes M Giesinger, Giorgio La Nasa, Francesco Sparano, et al.
Frontiers in Oncology|May 9, 2025
Impact of primary cancer history and molecular landscape in therapy-related myeloid neoplasmsAlessandro Costa, Federica Pilo, Martina Pettinau, et al.
Annals of Hematology|July 24, 2021
Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosisGiovanni Caocci, Olga Mulas, Daniela Mantovani, et al.
Clinical Practice and Epidemiology in Mental Health : CP & EMH|January 2, 2024
Understanding the User's Point of View: When the Doctor Gets Sick with Cancer and Seeks HelpElena Massa, Eleonora Lai, Clelia Donisi, et al.
Annals of Hematology|August 21, 2023
Renin-angiotensin inhibitors reduce thrombotic complications in Essential Thrombocythemia and Polycythemia Vera patients with arterial hypertensionOlga Mulas, Brunella Mola, Alessandro Costa, et al.
International Journal of Hematology|March 25, 2020
Increased incidence of infection in patients with myelofibrosis and transfusion-associated iron overload in the clinical settingGiovanni Caocci, Maria Pina Simula, Silvia Ghiani, et al.
Annals of Hematology|January 31, 2022
Health-related quality of life profile of patients with immune thrombocytopenia in the real life is impaired by splenectomyGiovanni Caocci, Fabio Efficace, Olga Mulas, et al.
Pageof 6

Showing results (11-20 of 57) with videos related to

Sort By:
Pageof 6
Acta Haematologica|September 6, 2020
Rituximab Monotherapy or in Combination with Bendamustine Is Not Inferior to Rituximab-CHOP Regimen in the Treatment of Patients with Splenic Marginal Zone Lymphoma in the Real LifeOlga Mulas, Giovanni Caocci, Daniela Dessì, et al.
Journal of Clinical Medicine|April 13, 2023
Long-Term Health-Related Quality of Life and Clinical Outcomes in Patients with β-Thalassemia after SplenectomyGiovanni Caocci, Olga Mulas, Susanna Barella, et al.
Diagnostics (Basel, Switzerland)|August 26, 2022
Pathogenic and Prognostic Roles of Paraneoplastic Leukocytosis in Cervical Cancer: Can Genomic-Based Targeted Therapies Have a Role? A Literature Review and an Emblematic Case ReportClelia Madeddu, Elisabetta Sanna, Sonia Nemolato, et al.
Clinical Practice and Epidemiology in Mental Health : CP & EMH|April 21, 2022
Health-Related Quality of Life Assessment in Patients with Myelodysplastic Syndromes: Evidence from Randomized Clinical TrialsJohannes M Giesinger, Giorgio La Nasa, Francesco Sparano, et al.
Frontiers in Oncology|May 9, 2025
Impact of primary cancer history and molecular landscape in therapy-related myeloid neoplasmsAlessandro Costa, Federica Pilo, Martina Pettinau, et al.
Annals of Hematology|July 24, 2021
Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosisGiovanni Caocci, Olga Mulas, Daniela Mantovani, et al.
Clinical Practice and Epidemiology in Mental Health : CP & EMH|January 2, 2024
Understanding the User's Point of View: When the Doctor Gets Sick with Cancer and Seeks HelpElena Massa, Eleonora Lai, Clelia Donisi, et al.
Annals of Hematology|August 21, 2023
Renin-angiotensin inhibitors reduce thrombotic complications in Essential Thrombocythemia and Polycythemia Vera patients with arterial hypertensionOlga Mulas, Brunella Mola, Alessandro Costa, et al.
International Journal of Hematology|March 25, 2020
Increased incidence of infection in patients with myelofibrosis and transfusion-associated iron overload in the clinical settingGiovanni Caocci, Maria Pina Simula, Silvia Ghiani, et al.
Annals of Hematology|January 31, 2022
Health-related quality of life profile of patients with immune thrombocytopenia in the real life is impaired by splenectomyGiovanni Caocci, Fabio Efficace, Olga Mulas, et al.
Pageof 6